EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Glucagon-like Peptide-1 Receptor (GLP-1R) Signaling: Making the Case for a Functionally Gs Protein-Selective GPCR

Anastasios Lymperopoulos iD, Victoria L Altsman, Renee A Stoicovy iD

International Journal of Molecular Sciences · 26.07.2025 · 26 (15) · 7239

DOI: 10.3390/ijms26157239 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.07.2025. Verfasst von Anastasios Lymperopoulos und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for the Study of Neurohormonal Control of the Circulation, Department of Pharmaceutical Sciences (Pharmacology), Barry and Judy Silverman …. Hauptthemen laut MEDLINE: Glucagon-Like Peptide-1 Receptor, Signal Transduction, GTP-Binding Protein alpha Subunits, Gs, Receptors, G-Protein-Coupled. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spurred by the enormous therapeutic success of glucagon-like peptide-1 receptor (GLP-1R) agonists (GLP1-RAs) against diabetes and obesity, glucagon family receptor pharmacology has garnered a tremendous amount of interest. Glucagon family receptors, e.g., the glucagon receptor itself (GCGR), the GLP-1R, and the glucose-dependent insulinotropic peptide receptor (GIPR), belong to the incretin receptor superfamily, i.e., receptors that increase blood glucose-dependent insulin secretion. All incretin receptors are class B1 G protein-coupled receptors (GPCRs), coupling to the Gs type of heterotrimeric G proteins which activates adenylyl cyclase (AC) to produce cyclic adenosine monophosphate (cAMP). Most GPCRs undergo desensitization, i.e., uncouple from G proteins and internalize, thanks to interactions with the βarrestins (arrestin-2 and -3). Since the βarrestins can also mediate their own G protein-independent signaling, any given GPCR can theoretically signal (predominantly) either via G proteins or βarrestins, i.e., be a G protein- or βarrestin-“biased” receptor, depending on the bound ligand. A plethora of experimental evidence suggests that the GLP-1R does not undergo desensitization in physiologically relevant tissues in vivo, but rather, it produces robust and prolonged cAMP signals. A particular property of constant cycling between the cell membrane and caveolae/lipid rafts of the GLP-1R may underlie its lack of desensitization. In contrast, GIPR signaling is extensively mediated by βarrestins and the GIPR undergoes significant desensitization, internalization, and downregulation, which may explain why both agonists and antagonists of the GIPR exert the same physiological effects. Here, we discuss this evidence and make a case for the GLP-1R being a phenotypically or functionally Gs-selective receptor. We also discuss the implications of this for the development of GLP-1R poly-ligands, which are increasingly pursued for the treatment of obesity and other diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucagon-Like Peptide-1 ReceptorSignal TransductionGTP-Binding Protein alpha Subunits, GsReceptors, G-Protein-CoupledHumansAnimalsCyclic AMP

Stichwörter der Autor:innen

G protein signalingagonist potencybiased signalingcyclic adenosine monophosphatedesensitizationglucagon family receptor poly-agonistglucagon-like peptide-1 receptorglucose-dependent insulinotropic peptide receptorβarrestin signaling

Substanzen

Glucagon-Like Peptide-1 ReceptorGTP-Binding Protein alpha Subunits, GsReceptors, G-Protein-CoupledCyclic AMP

Autor:innen und Institutionen

  • Laboratory for the Study of Neurohormonal Control of the Circulation, Department of Pharmaceutical Sciences (Pharmacology), Barry and Judy Silverman College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL…

ORCID-Profile: Anastasios Lymperopoulos, Renee A Stoicovy

Förderung

  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Lymperopoulos, A., Altsman, V. L., & Stoicovy, R. A. (2025). Glucagon-like Peptide-1 Receptor (GLP-1R) Signaling: Making the Case for a Functionally Gs Protein-Selective GPCR. International Journal of Molecular Sciences, 26(15), 7239. https://doi.org/10.3390/ijms26157239

Vancouver

Lymperopoulos A, Altsman VL, Stoicovy RA. Glucagon-like Peptide-1 Receptor (GLP-1R) Signaling: Making the Case for a Functionally Gs Protein-Selective GPCR. International Journal of Molecular Sciences. 2025;26(15):7239. doi:10.3390/ijms26157239

BibTeX
@article{Lymperopoulos2025,
  author = {Lymperopoulos, Anastasios and Altsman, Victoria L and Stoicovy, Renee A},
  title = {Glucagon-like Peptide-1 Receptor (GLP-1R) Signaling: Making the Case for a Functionally Gs Protein-Selective GPCR},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {15},
  pages = {7239},
  doi = {10.3390/ijms26157239}
}
Kostenlos starten →